대한상한금궤의학회지

  • 제14권1호
  • /
  • Pages.69-79
  • /
  • 2022
  • /
  • 2287-8696(pISSN)
  • /
  • 2288-744X(eISSN)
대한상한금궤의학회 (Korean Medical Association of Clinical Sanghan-Geumgwe)
권호 표지

『상한론(傷寒論)』 변병(辨病) 진단체계(診斷體系)에 근거하여 생강사심탕(生薑瀉心湯) 투여 후 호전된 피로를 주소로 하는 Post-COVID-19 Syndrome 1례

A Case Report of Post-COVID-19 Syndrome with Fatigue Treated with Saengkangsasim-tang based on Disease Pattern Identification Diagnostic System by Shanghanlun Provisions

  • 서영호 ( 서영호한의원 ) ;
  • 김상호 (대구한의대학교 한의과대학 신경정신과교실) ;
  • 황보민 (대구한의대학교 한의과대학 안이비인후피부과교실) ;
  • 최해윤 (대구한의대학교 한의과대학 내과학교실)
  • Young-ho Seo (Seo-Young-Ho Korean medicine clinic) ;
  • Sang-ho Kim (Dept. of Neuropsychiatry, College of Korean Medicine, Daegu Haany University) ;
  • Min Hwangbo (Dept. of Oriental Ophthalmology and Otolaryngology and Dermatology, College of Korean Medicine, Daegu Haany University) ;
  • Hae-Yun Choi (Dept. of Internal Medicine, College of Korean Medicine, Daegu Haany University)
  • 투고 : 2023.01.18
  • 심사 : 2023.01.20
  • 발행 : 2022.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective : Fatigue is the most common symptom in post-COVID-19 syndrome. We report the case of a patient with post-COVID-19 syndrome with fatigue treated using herbal medicine (Saengkangsasim-tang). Methods : A 64-year-old man had severe fatigue for 4 months after a severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection. Saengkangsasim-tang was administered to this patient based on the disease pattern identification diagnostic system by Shanghanlun provisions (DPIDS). We used the Numeric Rating Scale (NRS) and Beck Depression Inventory (BDI) to evaluate the effectiveness of Saengkangsasim-tang for fatigue in the patient with post-COVID-19 syndrome. Results : According to DPIDS, the patient was diagnosed with the provision 157. After administration of Saengkangsasim-tang for 30days, the fatigue based on NRS and depression based on BDI were improved. Conclusions : The administration of Saengkangsasim-tang to patients with post-COVID-19 syndrome with fatigue, diagnosed according to the Shanghanlun provision 157, may be effective.

키워드

참고문헌

  1. Raveendran A, Jayadevan R, Sashidharand S. Long COVID:an overview. Diabetes & Metabolic Syndrome:Clinical Research & Reviews. 2021;15(3):869-75. doi.org/10.1016/j.dsx.2021.04.007 
  2. Han Q, Zheng B, Daines L, Sheikh A. Long-Term sequelae of COVID-19:A systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens, 2022;11(2):269. doi.org/10.3390/pathogens11020269 
  3. Ceban F, Ling S, Lui L, Lee Y, Gill H, Teopiz K, Rodrigues N, Subramaniapillai M, Di Vincenzo J, Cao B, Lin K, Mansur R, Ho R, Rosenblat J, Miskowiak K, Vinberg M, Maletic V, McIntyre R. Fatigue and cognitive impairment in Post-COVID-19 Syndrome:A systematic review and meta-analysis. Brain, behavior, and immunity. 2022;101:93-135. doi.org/10.1016/j.bbi.2021.12.020 
  4. Latronico N, Peli E, Calza S, Rodella F, Novelli M, Cella A, Marshall J, Needham D, Rasulo F, Piva S. Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS. Thorax, 2022;77(3):300-303. doi.org/10.1136/thoraxjnl-2021-218064 
  5. Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, Hu P, Guo L, Liu M, Xu J, Zhang X, Qu Y, Fan Y, Li X, Li C, Yu T, Xia J, Wei M, Chen L, Li Y, Xiao F, Liu D, Wang J, Wang X, Cao B. 1-year outcomes in hospital survivors with COVID-19:a longitudinal cohort study. The lancet, 2021;398(10302):747-58. doi.org/10.1016/S0140-6736(21)01755-4 
  6. Sabes-Figuera R, McCrone P, Hurley M, King M, Donaldson A, Ridsdale L. The hidden cost of chronic fatigue to patients and their families. BMC health services research, 2010;10(1):1-7. doi.org/10.1186/1472-6963-10-56 
  7. LEE D, Li Q, Liu J, Efferth T. Traditional Chinese herbal medicine at the forefront battle against COVID-19:Clinical experience and scientific basis. Phytomedicine, 2021;80:153337. doi.org/10.1016/j.phymed.2020.153337 
  8. The Society of Stroke on Korean Medicine. Chronic Fatigue:Clinical Practice Guideline of Korean Medecine. Gunjachulpansa. 2021. 
  9. Tokumasu K. Ueda K, Honda H, Sunada N, Sakurada Y, Matsuda Y, Nakano Y, Hasegawa T, Otsuka Y, Obika M, Hagiya H, Kataika H, Otsuka F. Application of Kampo Medicines for Treatment of General Fatigue Due to Long COVID. Medicina, 2022;58(6):730. doi.org/10.3390/medicina58060730 
  10. Kumar A, Rai A, Khan M, Kumar A, Haque Z, Fazil M, Rabbani G. Role of herbal medicines in the management of patients with COVID-19:A systematic review and meta-analysis of randomized controlled trials. Journal of traditional and complementary medicine, 2022;12(1):100-13. doi.org/10.1016/j.jtcme.2022.01.002 
  11. Shiraish Y. Illustrate Shanghanlun. Jeonpagwahaksa. 2006:156-69. 
  12. Ryu JM, Hwang UW, Kim JW, Chi SE, Kim EJ, Park EH. The effects of Jowiseungchung-tang versus fluoxetine in the chronic mild stress model of depression in rats. J of Oriental Neuropsychiatry. 2004;15(1):43-64. 
  13. Lee SG, Ahn KS. Experimental Studies on the Kinds of Sasim-tang in Behcet's Disease Symptoms in ICR Mice. Korean J. Oriental Physiology & Pathology. 2004;18(4):1061-70. 
  14. Lee SJ, Lim JE. A diagnostic system and clinical application based on six meridian patterns and provisions. KMediACs publishing house. 2013. 
  15. Kim DD. A study on the naming of 'A diagnostic system based on Shanghanlun six meridian patterns and provisions and suggestion. Journal of Korean Medical Association of Clinical Sanghan-Geumgwe. 2013;5(1):19-29. doi.org/10.22891/kmedia.2013.5.1.19 
  16. Oh HM, Kim SW, Oh YT, Son CG, Lee JS. A comparative study on physiopathology of depression by Korean medicine and conventional medicine. Journal of Haehwa Medicine 2017;26(1):11-18. 
  17. Lee WJ. Two Cases of Headache Not Otherwise Classified Treated with Saengkangsasim-tang Based on Shanghanlun Provisions. Journal of Korean Medical Association of Clinical Sanghan-Geumgwe. 2021;13(1):133-144. doi.org/10.22891/kmedia.2021.13.1.133 
  18. Lee SI. Comparison of Shanghanlun. 1st edition KMediACs publishing house. 2015:198,206. 
  19. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, Luo J, Huang Zm Tu S, Zhao Y, Chen L, Xu D, Li Y, Li C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan G, Xu J, Wang G, Wang Y, Zhong J, Wang C, Wang J, Zhang D, Cao B. 6-month consequences of COVID-19 in patients discharged from hospital a cohort study. Lancet 2021;397(10270):220-32. doi.org/10.1016/S0140-6736(20)32656-8 
  20. Nalbandian A, Sehgal K, Gupta A, Madhavan M, McGroder C, Stenens J, Cook J, Nordvig A, Shalev D, Sehrawat T, Ahluwalia N, Bikdeli B, Dietz D, Der-Nigoghossian C, Liyanage-Don N, Rosner G, Bernstein E, Mohan S, Beckley A, Seres D, Choueiri T, Uriel N, Ausiello J, Accili D, Feedberg D, Baldwin M, Schwartz A, Brodie D, Garcia C, Elkind M, Conners J, Bilezikian J, Landry D, Wan E. Post-acute COVID-19 syndrome. Nature medicine. 2021;27:601-15. doi.org/10.1038/s41591-021-01283-z 
  21. Oh HM, Kim SW, Oh YT, Son CG, Lee JS. A comparative study on physiopathology of depression by Korean medicine and conventional medicine. Journal of Haehwa Medicine 2017;26(1):11-18. 
  22. Hwang UH, Kim JH. Oriental Psychiatry. Modern Medical books. 1987:505-529, 607-11. 
  23. Lee EH, Choi WC, Jung IC. Preliminary Study to Develop the Instrument on Pattern Identifications for Depression. J of Oriental Neuropsychiatry. 2013;24(4):435-50. doi.org/10.7231/jon.2013.24.4.435 
  24. Mun JJ, An GS, Kim SH, Eom HS, Ji GY, Kim JB, BAK JH. Sanghanlunjeonghae. 1998:330-1. 
  25. Ha YS . The Etymology Dictionary of Chinese Characters. Seoul. Publication 3. 2014:496, 762. 
  26. Ha HY, Lee SJ, Lee SI. Diagnostic of chest bind in GanPyeongShanghanlun 15 letters provision. Journal of Korean Medical Association of Clinical Sanghan-Geumgwe. 2018;10(1):1-21. 
  27. Committee on the Compilation of Basic 808 Chinese Characters. The Basic 808 Chinese Characters in China, Korea and Japan. JoongAng Ilbo. 2016:824. 
  28. Seo YH, Hwangbo M, Choi HY. A Case Report of Tinnitus Treated by Socheongryong-tang based on Shanghanlun Provisions. Journal of Korean Medical Association of Clinical Sanghan-Geumgwe. 2020;12(1):71-78. doi.org/10.22891/kmedia.2020.12.1.71 
  29. Krupp L, Larocca N, Muir-Nash J, Steinberg A. The fatigue severity scale:Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology. 1989;46(10):1121-1123. doi:10.1001/archneur.1989.00520460115022 
  30. Sivan M, Halpin S, Gee J. Assessing long-term rehabilitation needs in COVID-19 survivors using a telephone screening tool (C19-YRS tool). Advances in Clinical Neurosciences and Rehabilitation, 2020;19(4):14-17. doi.org/10.47795/nele5960